MAPT and amyotrophic lateral sclerosis: Similarly, patients with bulbar-onset ALS exhibited higher levels of tau protein (median 302.5 ng/l in bulbar-onset ALS vs. median 177.5 ng/l in the control group; p = 0.012, post hoc test).